IN
Indaptus Therapeutics, Inc.
INDP · NASDAQ
$3.77 -4.07% (-$0.16)
1M +243.97%
Market Cap $349.9M
P/E Ratio -
Div. Yield -
ROE 302.75%
Bulios Fair Price
$2.71
28.1% downside
Trenutna cena
$3.77
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica INDP trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 30.77x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 49.61%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 129.90%
ROE 302.75%
Asset turnover 0.00x
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 19.48x
Int. coverage N/A
Stability
25 /100
Unstable Beta 1.17x
EPS volatility 717.96%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o INDP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Junyi Dai
Employees
5
Headquarters
New York City
Prihajajoči dogodki
17 NOV.
Earnings
Upcoming earnings report